TY - JOUR
T1 - Simian virus-40 large-T antigen binds p53 in human mesotheliomas
AU - Carbone, Michele
AU - Rizzo, Paola
AU - Grimley, Philip M.
AU - Procopio, Antonio
AU - Mew, Daphne J.Y.
AU - Shridhar, Viji
AU - De Bartolomeis, Andrea
AU - Esposito, Vincenzo
AU - Giuliano, Maria Teresa
AU - Steinberg, Seth M.
AU - Levine, Arthur S.
AU - Giordano, Antonio
AU - Pass, Harvey I.
PY - 1997/8
Y1 - 1997/8
N2 - We found that similar virus 40 (SV 40) induces mesotheliomas in hamsters' and that 0% of human mesotheliomas contain and express SV40 sequences, results now confirmed by others [ref. 3-5, and presentations by D. Griffiths and R. Weiss, F. Galateau SallE, and H.I.P. at 'Similar virus 40: A possible human polyomal virus,' NIH workshop, 27-28 January 1997, Bethesda, MD (transcript available through SAG Corp., Washington, S.C. 20008)]. Mesothelioma, an aggressive malignancy resistant to therapy, originates from the serosal lining of the pleural, pericardial and peritoneal cavities. The incidence of mesothelioma continues to increase worldwide because of exposure to crocidolite asbestos. However, at least 20% of mesotheliomas in the United States are not associated with asbestos exposure, and only a minority of people exposed to high concentrations of asbestos develop mesothelioma. Thus, other carcinogens may induce mesothelioma in individuals not exposed to asbestos, and/or may render particular individuals more susceptible to the carcinogenic effect of asbestos. We investigated whether the expression of the SV40 large T- antigen (Tag) interferes wit the normal express of the asbestos. We investigated whether the expression of the SV40 large T-antigen (Tag) interferes with the normal expression of the tumor suppressor gene p53 in human mesotheliomas. We found that SV40 Tag retains its ability to bind and to inactive p53, a cellular protein that when normally expressed plays an important role in suppressing tumor growth and in inducing sensitivity to therapy. Our findings do not establish a cause-and-effect relation, but indicate that the possibility that SV40 contributes to the development of human mesotheliomas should be carefully investigated.
AB - We found that similar virus 40 (SV 40) induces mesotheliomas in hamsters' and that 0% of human mesotheliomas contain and express SV40 sequences, results now confirmed by others [ref. 3-5, and presentations by D. Griffiths and R. Weiss, F. Galateau SallE, and H.I.P. at 'Similar virus 40: A possible human polyomal virus,' NIH workshop, 27-28 January 1997, Bethesda, MD (transcript available through SAG Corp., Washington, S.C. 20008)]. Mesothelioma, an aggressive malignancy resistant to therapy, originates from the serosal lining of the pleural, pericardial and peritoneal cavities. The incidence of mesothelioma continues to increase worldwide because of exposure to crocidolite asbestos. However, at least 20% of mesotheliomas in the United States are not associated with asbestos exposure, and only a minority of people exposed to high concentrations of asbestos develop mesothelioma. Thus, other carcinogens may induce mesothelioma in individuals not exposed to asbestos, and/or may render particular individuals more susceptible to the carcinogenic effect of asbestos. We investigated whether the expression of the SV40 large T- antigen (Tag) interferes wit the normal express of the asbestos. We investigated whether the expression of the SV40 large T-antigen (Tag) interferes with the normal expression of the tumor suppressor gene p53 in human mesotheliomas. We found that SV40 Tag retains its ability to bind and to inactive p53, a cellular protein that when normally expressed plays an important role in suppressing tumor growth and in inducing sensitivity to therapy. Our findings do not establish a cause-and-effect relation, but indicate that the possibility that SV40 contributes to the development of human mesotheliomas should be carefully investigated.
UR - http://www.scopus.com/inward/record.url?scp=0030758710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030758710&partnerID=8YFLogxK
U2 - 10.1038/nm0897-908
DO - 10.1038/nm0897-908
M3 - Article
C2 - 9256284
AN - SCOPUS:0030758710
SN - 1078-8956
VL - 3
SP - 908
EP - 912
JO - Nature Medicine
JF - Nature Medicine
IS - 8
ER -